Efficacy and Safety of DBS in Patients With Primary Dystonia
Subthalamic Nucleus (STN) and Globus Pallidus Internus (GPi) Deep Brain Stimulation (DBS) in Patients With Primary Dystonia(RELAX Study)
1 other identifier
interventional
72
1 country
7
Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of deep brain stimulation (DBS) of the subthalamic nucleus (STN) and globus pallidus internus (GPi) for primary dystonia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2017
Longer than P75 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2017
CompletedFirst Posted
Study publicly available on registry
January 11, 2017
CompletedStudy Start
First participant enrolled
December 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2021
CompletedAugust 7, 2024
August 1, 2024
2.7 years
January 5, 2017
August 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
change in Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) movement score
3,6 months
Secondary Outcomes (6)
Short-Form General Health Survey (SF-36)
3,6 monthsthe Beck Anxiety Inventory31 (with scores ranging from 0 to 63 and higher scores indicating more severe anxiety)
Visual analogue scale
3,6 months
Measurements of walking
3,6 months
The Beck Depression Inventory
3,6 months
Mini-Mental State Examination
3,6 months
- +1 more secondary outcomes
Study Arms (2)
STN
EXPERIMENTALDBS target with Subthalamic Nucleus (STN).
GPi
EXPERIMENTALDBS target with Globus Pallidus Internus (GPi).
Interventions
Deep Brain Stimulation for primary dystonia subjects
Eligibility Criteria
You may qualify if:
- Refractory primary (systemic, segmental) dystonia diagnosed by a movement disorders neurologist
- Severe functional impairment despite optimal medical management, including failed botulinum toxin therapy
- Ability to follow up with post-operative study visits
- Patients and their relatives have reasonable surgery expectations
- Volunteer to participate in clinical trials, and signed consent form
- Age 6-60 years
You may not qualify if:
- Pregnancy or plan a pregnancy
- Good treatment with Non-invasive therapy
- Dopamine reactive dystonia ,Genetic degeneration ,Paroxysmal dystonia ,Secondary dystonia, Psychogenic dystonia
- Brain MRI showing extensive brain atrophy or small vessel ischemic disease
- Cognitive impairment(MMSE\<24)
- Severe depression or other serious mental illness
- History of traumatic brain injury, tumor, or severe cerebrovascular disease
- Severe brain atrophy (diagnosed by CT or MRI)
- Hyperthermia therapy in implant parts
- Abnormal in blood inspection, blood clotting disorders, liver and kidney dysfunction, or other clinical judgment cannot tolerate surgery
- High blood pressure, serious heart diseases, or respiratory diseases
- Diabetes
- Long-term treatment of immunosuppressive or hormones
- Implant pacemakers, defibrillators, cochlear and other nerve stimulators
- Other diseases need frequent MRI examinations
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Beijing Union Medical College Hospital
Beijing, Beijing Municipality, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
Nanjing Brain Hospital
Nanjing, Jiangsu, China
Qilu Hospital of Shandong University
Jinan, Shandong, China
Tongji Hospital of Tongji Univeristy
Shanghai, Shanghai Municipality, China
West China Hospital Sichuan University
Chengdu, Sichuan, China
Sir Run Run Shaw Hospital,School of Medicine,Zhejiang University
Hangzhou, Zhejiang, China
Related Publications (19)
Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol. 1987;50(1-6):344-6. doi: 10.1159/000100803.
PMID: 3329873BACKGROUNDDeep-Brain Stimulation for Parkinson's Disease Study Group; Obeso JA, Olanow CW, Rodriguez-Oroz MC, Krack P, Kumar R, Lang AE. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med. 2001 Sep 27;345(13):956-63. doi: 10.1056/NEJMoa000827.
PMID: 11575287BACKGROUNDKrack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A, Benabid AL. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain. 1998 Mar;121 ( Pt 3):451-7. doi: 10.1093/brain/121.3.451.
PMID: 9549521BACKGROUNDHerzog J, Volkmann J, Krack P, Kopper F, Potter M, Lorenz D, Steinbach M, Klebe S, Hamel W, Schrader B, Weinert D, Muller D, Mehdorn HM, Deuschl G. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord. 2003 Nov;18(11):1332-7. doi: 10.1002/mds.10518.
PMID: 14639676BACKGROUNDBeric A, Kelly PJ, Rezai A, Sterio D, Mogilner A, Zonenshayn M, Kopell B. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg. 2001;77(1-4):73-8. doi: 10.1159/000064600.
PMID: 12378060BACKGROUNDOh MY, Abosch A, Kim SH, Lang AE, Lozano AM. Long-term hardware-related complications of deep brain stimulation. Neurosurgery. 2002 Jun;50(6):1268-74; discussion 1274-6. doi: 10.1097/00006123-200206000-00017.
PMID: 12015845BACKGROUNDUmemura A, Jaggi JL, Hurtig HI, Siderowf AD, Colcher A, Stern MB, Baltuch GH. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg. 2003 Apr;98(4):779-84. doi: 10.3171/jns.2003.98.4.0779.
PMID: 12691402BACKGROUNDBenazzouz A, Piallat B, Pollak P, Benabid AL. Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci Lett. 1995 Apr 14;189(2):77-80. doi: 10.1016/0304-3940(95)11455-6.
PMID: 7609923BACKGROUNDBenazzouz A, Gao DM, Ni ZG, Piallat B, Bouali-Benazzouz R, Benabid AL. Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience. 2000;99(2):289-95. doi: 10.1016/s0306-4522(00)00199-8.
PMID: 10938434BACKGROUNDDostrovsky JO, Levy R, Wu JP, Hutchison WD, Tasker RR, Lozano AM. Microstimulation-induced inhibition of neuronal firing in human globus pallidus. J Neurophysiol. 2000 Jul;84(1):570-4. doi: 10.1152/jn.2000.84.1.570.
PMID: 10899228BACKGROUNDFilali M, Hutchison WD, Palter VN, Lozano AM, Dostrovsky JO. Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus. Exp Brain Res. 2004 Jun;156(3):274-81. doi: 10.1007/s00221-003-1784-y. Epub 2004 Jan 24.
PMID: 14745464BACKGROUNDTai CH, Boraud T, Bezard E, Bioulac B, Gross C, Benazzouz A. Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB J. 2003 Oct;17(13):1820-30. doi: 10.1096/fj.03-0163com.
PMID: 14519661BACKGROUNDHashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci. 2003 Mar 1;23(5):1916-23. doi: 10.1523/JNEUROSCI.23-05-01916.2003.
PMID: 12629196BACKGROUNDMcIntyre CC, Grill WM, Sherman DL, Thakor NV. Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition. J Neurophysiol. 2004 Apr;91(4):1457-69. doi: 10.1152/jn.00989.2003. Epub 2003 Dec 10.
PMID: 14668299BACKGROUNDKupsch A, Benecke R, Muller J, Trottenberg T, Schneider GH, Poewe W, Eisner W, Wolters A, Muller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Vollmer-Haase J, Brentrup A, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Naumann M, Volkmann J; Deep-Brain Stimulation for Dystonia Study Group. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med. 2006 Nov 9;355(19):1978-90. doi: 10.1056/NEJMoa063618.
PMID: 17093249BACKGROUNDVidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, Lagrange C, Tezenas du Montcel S, Dormont D, Grand S, Blond S, Detante O, Pillon B, Ardouin C, Agid Y, Destee A, Pollak P; French Stimulation du Pallidum Interne dans la Dystonie (SPIDY) Study Group. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med. 2005 Feb 3;352(5):459-67. doi: 10.1056/NEJMoa042187.
PMID: 15689584BACKGROUNDVolkmann J, Wolters A, Kupsch A, Muller J, Kuhn AA, Schneider GH, Poewe W, Hering S, Eisner W, Muller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Classen J, Naumann M, Benecke R; DBS study group for dystonia. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol. 2012 Dec;11(12):1029-38. doi: 10.1016/S1474-4422(12)70257-0. Epub 2012 Nov 1.
PMID: 23123071BACKGROUNDCao C, Pan Y, Li D, Zhan S, Zhang J, Sun B. Subthalamus deep brain stimulation for primary dystonia patients: a long-term follow-up study. Mov Disord. 2013 Nov;28(13):1877-82. doi: 10.1002/mds.25586. Epub 2013 Jul 16.
PMID: 23861342BACKGROUNDWang L, Shang H, Jin L, Xiong N, Hu X, Wang W, Liu Y, Yan J, Gao L, Wang Y, Wang Y, Fu P, Cai H, Zhang W, Xu S, Teng F, Ou R, Qiao L, Yang Y, Zhang M, Guo Y, Wan X. Subthalamic deep brain stimulation in isolated generalised or segmental dystonia (RELAX Study): a multicentre, randomised, double-blind, controlled trial. J Neurol Neurosurg Psychiatry. 2025 Oct 15;96(11):1077-1088. doi: 10.1136/jnnp-2025-335829.
PMID: 40480805DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 5, 2017
First Posted
January 11, 2017
Study Start
December 27, 2017
Primary Completion
September 13, 2020
Study Completion
December 17, 2021
Last Updated
August 7, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- De-identified data may be available after results have been published
- Access Criteria
- Individual participant data is available upon request.
Individual participant data is available upon request.